Cerevast Therapeutics
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12100 NE 195th St Ste 150, Bothell, Wash...Phone Number
(425) 748-7529Website
www.cerevast.comRevenue
<$5 MillionIndustry
About Cerevast Therapeutics
Cerevast Therapeutics Org Chart
Is Cerevast Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cerevast Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Cerevast Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cerevast Therapeutics launches new products
Funding: Get notified immidiatlly once Cerevast Therapeutics has new funding data
Earning: See what the market has to say on Cerevast Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cerevast Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cerevast Therapeutics
Check out if Cerevast Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Cerevast Therapeutics
Find 3 more new buyers
Compare Similar Companies to Cerevast Therapeutics
Compare insights from companies similar to Cerevast Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cerevast Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cerevast Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cerevast Therapeutics.
Cerevast Therapeutics financials insights
Gather financial insights about Cerevast Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$900K
Debt
$1.8M
Series B
$22.4M
Series C
$11.4M
Cerevast Therapeutics Tech Stack
A closer look at the technologies used by Cerevast Therapeutics
Cerevast Therapeutics News & Media
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cerevast Therapeutics
Cerevast specializes in innovative health restoration programs focusing on conditions such as Retinal Vein Occlusion (RVO) and stroke. The company employs advanced technologies including microsphere-mediated ophthalmic ultrasound and transcranial ultrasound techniques to enhance treatment outcomes. Their target clients include patients suffering fr... Read More